Effect of Botulinum Toxin on the Spatial Distribution of Biceps Brachii EMG Activity Using a Grid of Surface...

Botulinum toxin (BT) is widely prescribed by physicians for managing spasticity post stroke. In an ongoing study, we examine the spatial pattern of muscle activity in biceps brachii of stroke survivors before and after receiving BT, examined over the course of 11 weeks (2 weeks before - 9 weeks after). We hypothesize that BT alters muscle electrophysiology by disrupting fiber neuromuscular transmission in an inhomogeneous manner and we seek to detect these changes using grid surface electromyography (sEMG). Also, we obtained B-mode ultrasound images to have an accurate interpretation of sEMG data by looking at the fiber angle and subcutaneous fat thickness distribution across muscle. Here, we are reporting a single case where a chronic stroke survivor received BT injection in the biceps brachii (BB). A 16x8 sEMG electrode grid was used to capture the muscle activity distribution of BB during sustained non-fatiguing isometric contraction at 40% of maximal voluntary (MVC) elbow flexion. We obtained the root mean squared (RMS) maps of the signal recorded at each of the $16 \times 8$ electrodes. We observed substantial changes in the RMS pattern of BB muscle after receiving BT. More than 80% decrease in sEMG amplitude (RMS) was observed for the channels around the BT injection site as well as about 74% elbow flexion force reduction at the time point of 3-4 weeks post-injection. We also found significant differences between the spatial voluntary activation pattern of pre and post BT RMS maps. We further observed a non-uniform effect and recovery caused by the BT on the distribution of muscle activity. In conclusion, we observed evidence of alteration of the amplitude and pattern of muscle activity after botulinum toxin injection and can document the capability of grid recordings to detect these pattern changes. Our major goals target further investigation to provide an indepth understanding of the effect of botulinum toxin injection at motor unit level.